Handelsbanken Fonder Ab Mersana Therapeutics, Inc. Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding MRSN
# of Institutions
136Shares Held
101MCall Options Held
77.2KPut Options Held
453K-
Nextech Invest Ag12.1MShares$5.55 Million3.22% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$5.21 Million0.76% of portfolio
-
Vr Adviser, LLC New York, NY10.3MShares$4.72 Million2.42% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$3.99 Million3.35% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$3.86 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $44.7M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...